Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for CBGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
August 31, 2025 -0.112M
May 31, 2025 -0.178M
February 28, 2025 0.00
November 30, 2024 0.00
August 31, 2024 0.00
May 31, 2024 0.00
February 29, 2024 -0.0651M
November 30, 2023 0.00
August 31, 2023 -0.003M
May 31, 2023 -0.0212M
February 28, 2023 0.0326M
November 30, 2022 -0.1066M
August 31, 2022 -0.2917M
May 31, 2022 -0.2384M
February 28, 2022 -0.3375M
November 30, 2021 -0.1162M
August 31, 2021 -0.15M
May 31, 2021 -0.5466M
February 28, 2021 -0.4795M
November 30, 2020 -0.295M
August 31, 2020
May 31, 2020 -0.5353M
February 29, 2020 -0.3373M
November 30, 2019 -0.1824M
August 31, 2019 -0.0763M
Date Value
May 31, 2019 -0.0178M
February 28, 2019 0.00
November 30, 2018 -0.0153M
August 31, 2018 -0.0071M
May 31, 2018 -0.0233M
February 28, 2018 0.00
November 30, 2017 -0.0053M
August 31, 2017 0.00
May 31, 2017 0.00
February 28, 2017 0.00
November 30, 2016 0.00
August 31, 2016 -0.0002M
May 31, 2016 -0.0002M
February 29, 2016 -0.0002M
November 30, 2015 -0.0002M
August 31, 2015 -0.0095M
May 31, 2015 -0.006M
February 28, 2015 -0.0221M
November 30, 2014 -0.0083M
August 31, 2014 -0.008M
May 31, 2014 -0.0108M
February 28, 2014 -0.0104M
November 30, 2013 -0.0102M
August 31, 2013 -0.0063M
May 31, 2013 -0.013M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. -3.855M
CorMedix, Inc. 86.06M
Eloxx Pharmaceuticals, Inc. -4.789M
Breakthrough Chemistry, Inc. -0.0073M
BioStem Technologies, Inc. -5.538M